Furthermore, obesity and metabolic dysfunction, including diabetes, are the main comorbidities that are associated with HFpEF [19], whereas SFRP5 has been previously shown to be influenced by obesity and metabolic dysfunction [6,10,20]. Here, SFRP5 is linked to obesity due to melanocortin 4 receptor deficiency.